Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407)

  1. Sarafidis, P.
  2. Ferro, C.J.
  3. Morales, E.
  4. Ortiz, A.
  5. Malyszko, J.
  6. Hojs, R.
  7. Khazim, K.
  8. Ekart, R.
  9. Valdivielso, J.
  10. Fouque, D.
  11. London, G.M.
  12. Massy, Z.
  13. Ruggenenti, P.
  14. Porrini, E.
  15. Wiecek, A.
  16. Zoccali, C.
  17. Mallamaci, F.
  18. Hornum, M.
Revista:
Nephrology Dialysis Transplantation

ISSN: 1460-2385,  0931-0509

Any de publicació: 2020

Volum: 35

Número: 8

Pàgines: 1452

Tipus: Errata

DOI: 10.1093/NDT/GFZ047 GOOGLE SCHOLAR lock_openAccés obert editor

Objectius de Desenvolupament Sostenible

Font de les dades: Scopus